Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6VAW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,662
Award facts
- Contract value 100% obligated
- $21,662.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,662.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, with completion targeted for January 7, 2026. The contract calls for the supply of Enbrel 50 mg/mL SureClick auto-injectors, a biologic therapeutic agent commonly used to treat rheumatoid arthritis and other autoimmune conditions. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle that runs through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company Cencora, Inc. (operating as AmerisourceBergen) holding the underlying IDC.
The delivery order represents routine pharmaceutical procurement to support military healthcare operations and the Defense Health Agency. AmerisourceBergen's role as a major pharmaceutical distributor enables it to fulfill federal medical supply needs across multiple therapeutic domains through its established relationship with DLA. The firm fixed-price structure and rapid completion timeline reflect standard practices for delivery orders placed against pre-established indefinite delivery contracts, allowing the government to efficiently procure critical biopharmaceutical products required by military treatment facilities and healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F6VAW?
SPE2DR26F6VAW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F6VAW worth?
The government has obligated $21,662 on SPE2DR26F6VAW.
Is contract SPE2DR26F6VAW an order under another contract?
Yes. SPE2DR26F6VAW is a delivery order under SPE2DR25D3802, an indefinite delivery contract.
Was contract SPE2DR26F6VAW competed?
The extent of competition for SPE2DR26F6VAW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award